To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene PPCSandCCDC30TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
393 supporting clones for gene PPCSandCCDC30 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001080850.2   .a 1 to 3098 1 to 3098 exact RefSeq,   3098/3098
(100 %)
0 diff
(100 %id)
BM714429 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1975 to 2214 1 to 240   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 240/240
(100 %)
0 diff
(100 %id)
BM675220 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2153 to 2623 489 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 471/471
(100 %)
0 diff
(100 %id)
AW364693 denis_drash .a 2199 to 2774 1 to 576   tiling clone,   576/576
(100 %)
6 diff
(99.0 %id)
AA927791 pooled .a 2227 to 2624 401 to 3       399/401
(99 %)
0 diff
(100 %id)
AI478530 Kidney .a 2282 to 2624 350 to 8       343/350
(98 %)
0 diff
(100 %id)
AW296607   .a 2294 to 2623 347 to 18   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 330/337
(97 %)
2 diff
(99.5 %id)
FN166661 breast carcinoma .a 2552 to 2619 1 to 68       68/71
(95 %)
2 diff
(97.2 %id)
AY639646   .b 1 to 2445 1 to 2445 E71G tiling clone,   2445/2445
(100 %)
2 diff
(100.0 %id)
DA009520 adrenal gland .c 1 to 554 2 to 555   tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
AL832217 human testis .c 68 to 3715 1 to 3648 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 3648/3648
(100 %)
2 diff
(100.0 %id)
DN831743 pooled .c 1843 to 1975 79 to 211       133/211
(63 %)
9 diff
(95.8 %id)
DN831332 pooled .c 1949 to 2256 308 to 1     Submitted on the opposite strand 308/308
(100 %)
2 diff
(99.4 %id)
DN831833 pooled .c 1986 to 2762 1 to 777       777/777
(100 %)
2 diff
(99.8 %id)
DN831331 pooled .c 1991 to 2302 1 to 313       313/313
(100 %)
2 diff
(99.4 %id)
TI_149308131   .c 2058 to 2584 598 to 71   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 528/1041
(50 %)
18 diff
(98.3 %id)
AW103198 ovary, tumor, 5 pooled (see description) .c 2064 to 2573 510 to 1       510/510
(100 %)
2 diff
(99.7 %id)
BU687005 lung, Primary Lung Epithelial Cells .c 2129 to 2584 464 to 8   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 457/464
(98 %)
5 diff
(99.0 %id)
DN831832 pooled .c 2587 to 2781 194 to 1     Submitted on the opposite strand 194/208
(93 %)
6 diff
(97.2 %id)
DB295219 adrenal gland .c 2621 to 3165 545 to 1       545/545
(100 %)
1 diff
(99.9 %id)
FN088049 breast carcinoma .c 2713 to 2798 1 to 86       86/86
(100 %)
3 diff
(96.6 %id)
BX091376 Kidney .c 2762 to 3150 1 to 389       389/389
(100 %)
0 diff
(100 %id)
CF618991 Pooled Chondrosarcoma Tumor cells .c 2786 to 3194 9 to 417       409/1038
(39 %)
9 diff
(99.2 %id)
CV365748 nervous_normal .c 2847 to 3083 8 to 245       238/245
(97 %)
11 diff
(95.6 %id)
AW896446 nervous_normal .c 2878 to 3080 199 to 1       199/199
(100 %)
13 diff
(93.5 %id)
AW896540 nervous_normal .c 2878 to 3082 207 to 2       206/207
(99 %)
1 diff
(99.6 %id)
AI768440 Kidney .c 3274 to 3715 465 to 24   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 442/442
(100 %)
9 diff
(98.0 %id)
BP202073 amygdala .d 1 to 579 1 to 579   tiling clone,   579/582
(99 %)
2 diff
(99.7 %id)
AK302075 testis .d 372 to 1937 1 to 1566 exact tiling clone,   1566/1566
(100 %)
0 diff
(100 %id)
DC397297 testis .d 372 to 914 1 to 545       545/545
(100 %)
2 diff
(99.7 %id)
BC104938 Brain, cerebral cortex, PCR rescued clones .e 1 to 1388 1 to 1388 exact     1388/1388
(100 %)
1 diff
(100.0 %id)
BC112015 Brain, cerebral cortex, PCR rescued clones .e 1 to 1390 1 to 1390 exact tiling clone,   1390/1390
(100 %)
0 diff
(100 %id)
TI_1241110677   .e 1 to 1134 49 to 1162 I285*     1114/1216
(91 %)
27 diff
(97.8 %id)
TI_1242415746   .e 1 to 1074 48 to 1109 E282G E283G E293R K294D I295S ...     1062/1180
(90 %)
16 diff
(98.7 %id)
TI_1242418368   .e 1 to 1107 51 to 1146 E275G T276N K277Q L278V L279I ... AAA   1078/1273
(84 %)
24 diff
(98.2 %id)
NM_024664.2   .e 9 to 1497 1 to 1489 exact RefSeq,   1489/1489
(100 %)
0 diff
(100 %id)
BG611874 adenocarcinoma, Prostate .e 19 to 761 32 to 774       745/788
(94 %)
36 diff
(95.5 %id)
CB995985 placenta, pre-eclamptic placenta .e 35 to 769 24 to 763       740/766
(96 %)
16 diff
(98.0 %id)
BG675097 skin .e 36 to 901 1 to 864       864/864
(100 %)
34 diff
(96.1 %id)
CB131138 Liver .e 37 to 548 1 to 512       512/512
(100 %)
0 diff
(100 %id)
CR619545 T cells (Jurkat cell line) Cot10-normalized .e 38 to 1531 1 to 1494 exact     1494/1494
(100 %)
0 diff
(100 %id)
AL558830 T cells from T cell leukemia .e 38 to 981 1 to 940       940/944
(99 %)
5 diff
(99.5 %id)
BM844185 lymph node, stomach .e 38 to 548 1 to 511       511/511
(100 %)
1 diff
(99.9 %id)
BP211396 cerebrum .e 39 to 618 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CB996490 placenta, pre-eclamptic placenta .e 39 to 684 27 to 673       647/734
(88 %)
8 diff
(99.0 %id)
BM761358 lymph node, stomach .e 39 to 481 1 to 443       443/443
(100 %)
0 diff
(100 %id)
BM843490 lymph node, stomach .e 39 to 476 1 to 435       435/435
(100 %)
13 diff
(97.1 %id)
BM846448 lymph node, stomach .e 39 to 451 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
DA377635 thalamus .e 42 to 516 2 to 478   capped   477/477
(100 %)
3 diff
(99.4 %id)
CN259742 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 42 to 757 4 to 720       717/720
(99 %)
7 diff
(99.1 %id)
DA829903 placenta .e 42 to 708 2 to 671   capped   670/671
(99 %)
10 diff
(98.6 %id)
BP323564 Pancreas .e 42 to 621 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DB004842 breast, tumor tissue .e 42 to 573 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BG492693 lung, mucoepidermoid carcinoma .e 46 to 684 1 to 658       658/949
(69 %)
33 diff
(96.6 %id)
BG533762 Liver .e 47 to 858 1 to 813       813/868
(93 %)
47 diff
(94.6 %id)
BF383040 brain, primitive neuroectoderm .e 49 to 684 1 to 644       600/893
(67 %)
50 diff
(94.5 %id)
DB480209 hippocampus .e 50 to 574 1 to 525       525/531
(98 %)
25 diff
(95.3 %id)
DB494947 hypothalamus .e 50 to 535 1 to 486       486/486
(100 %)
1 diff
(99.8 %id)
BP264463 small intestine .e 50 to 631 1 to 583       583/584
(99 %)
5 diff
(99.2 %id)
BC106064 Uterus, leiomyosarcoma .e 51 to 1496 1 to 1446 exact tiling clone, AAA   1446/1446
(100 %)
1 diff
(100.0 %id)
DA359881 subthalamic nucleus .e 51 to 618 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
TI_57216615   .e 53 to 779 53 to 779       727/780
(93 %)
7 diff
(99.2 %id)
CR595942 Neuroblastoma Cot 25-normalized .e 55 to 1450 1 to 1396 exact     1396/1396
(100 %)
0 diff
(100 %id)
AL525081 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 55 to 715 1 to 661   fully sequenced,   661/661
(100 %)
5 diff
(99.3 %id)
BG701334 brain, hippocampus .e 59 to 752 1 to 695       695/696
(99 %)
8 diff
(98.9 %id)
BI756242 brain .e 59 to 779 1 to 721       721/722
(99 %)
2 diff
(99.8 %id)
FN100252 breast carcinoma .e 60 to 126 67 to 1     Submitted on the opposite strand 67/68
(98 %)
3 diff
(95.6 %id)
BG705257 brain, hippocampus .e 60 to 859 1 to 806       806/808
(99 %)
14 diff
(98.3 %id)
BU194219 bone marrow, from acute myelogenous leukemia .e 63 to 682 1 to 622       622/824
(75 %)
24 diff
(97.1 %id)
BP327648 prostata .e 64 to 644 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BX503295 Liver .e 65 to 460 1 to 396       396/396
(100 %)
3 diff
(99.3 %id)
BF102898 adenocarcinoma, Prostate .e 65 to 810 1 to 730       733/812
(90 %)
45 diff
(94.5 %id)
BG533597 Liver .e 65 to 847 1 to 787       787/788
(99 %)
23 diff
(97.1 %id)
AK021900 whole embryo, mainly head .e 66 to 1496 1 to 1430 E282R E283K E284K I285* available from FLJ,   1430/1430
(100 %)
4 diff
(99.8 %id)
DA067772 cerebellum .e 67 to 643 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
FN165288 breast carcinoma .e 67 to 136 1 to 67       67/70
(95 %)
4 diff
(94.3 %id)
AU119781 whole embryo, mainly head .e 67 to 798 2 to 737   capped   736/744
(98 %)
9 diff
(98.8 %id)
BM546400 ovary (pool of 3) .e 67 to 1047 12 to 996 E9*     985/1103
(89 %)
37 diff
(96.7 %id)
DA699230   .e 68 to 551 2 to 485   capped   484/484
(100 %)
3 diff
(99.4 %id)
BM828603 Ascites, stomach .e 69 to 184 1 to 116       116/148
(78 %)
2 diff
(98.7 %id)
DA842644 placenta .e 70 to 579 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
BP208010 cerebellum .e 71 to 650 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AA614438 breast .e 71 to 389 1 to 315     Submitted on the opposite strand 315/317
(99 %)
5 diff
(98.5 %id)
BP314120 mammary gland .e 71 to 652 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BE887715 leiomyosarcoma, uterus .e 72 to 820 1 to 744       744/923
(80 %)
19 diff
(98.0 %id)
BE740898 adenocarcinoma cell line, ovary .e 72 to 780 1 to 720       720/738
(97 %)
39 diff
(94.8 %id)
TI_57199932   .e 72 to 921 64 to 915       852/1092
(78 %)
24 diff
(97.9 %id)
BU594749 mixed (pool of 40 RNAs) .e 73 to 838 1 to 773       773/826
(93 %)
24 diff
(97.1 %id)
AW630144 2 pooled high-grade transitional celltumors, genitourinary tract .e 75 to 363 8 to 296       289/296
(97 %)
6 diff
(98.0 %id)
BF684413 leiomyosarcoma cell line, uterus .e 75 to 830 1 to 763       763/1062
(71 %)
26 diff
(97.6 %id)
BI818951 pooled brain, lung, testis .e 75 to 921 1 to 849       849/1026
(82 %)
22 diff
(97.9 %id)
BQ213084 melanotic melanoma, skin .e 75 to 681 22 to 632       611/987
(61 %)
16 diff
(98.4 %id)
BP303519   .e 75 to 654 1 to 581       581/581
(100 %)
15 diff
(97.5 %id)
BE730718 choriocarcinoma, placenta .e 76 to 920 1 to 844       844/889
(94 %)
18 diff
(98.0 %id)
BQ636013 eye, retina .e 77 to 684 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BQ636866 eye, retina .e 77 to 653 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BI334597 cervical carcinoma cell line, cervix .e 77 to 742 1 to 666       666/666
(100 %)
0 diff
(100 %id)
BM918834 pooled pancreas and spleen .e 77 to 918 19 to 867       849/1154
(73 %)
43 diff
(96.3 %id)
CX758881 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 77 to 763 1 to 682     Submitted on the opposite strand 682/791
(86 %)
21 diff
(97.4 %id)
BQ960008 leiomyosarcoma, uterus .e 78 to 925 1 to 853       853/878
(97 %)
15 diff
(98.3 %id)
DA668358 esophagus .e 79 to 573 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
CR615199 Placenta Cot 25-normalized .e 84 to 1460 1 to 1377       1377/1377
(100 %)
0 diff
(100 %id)
BX356087 Placenta Cot 25-normalized .e 84 to 715 1 to 631   fully sequenced,   631/631
(100 %)
1 diff
(99.9 %id)
BG480164 choriocarcinoma, placenta .e 84 to 947 1 to 855       857/856
(100 %)
63 diff
(92.7 %id)
BM083605 choriocarcinoma, placenta .e 84 to 752 1 to 670       670/670
(100 %)
3 diff
(99.6 %id)
BM545261 brain, hippocampus .e 84 to 1047 9 to 979       971/1086
(89 %)
39 diff
(96.5 %id)
BM791961 Ascites, stomach .e 84 to 653 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
BM827504 Ascites, stomach .e 84 to 478 1 to 395       395/395
(100 %)
1 diff
(99.8 %id)
DN991120 brain, whole brain .e 84 to 655 31 to 602       572/602
(95 %)
8 diff
(98.7 %id)
BQ950182 large cell carcinoma, lung .e 86 to 780 1 to 704       704/882
(79 %)
15 diff
(98.3 %id)
BI756261 brain .e 87 to 919 1 to 838       838/848
(98 %)
17 diff
(98.0 %id)
TI_57216635   .e 87 to 919 34 to 871       838/881
(95 %)
21 diff
(97.7 %id)
BQ225859 embryonal carcinoma, cell line, testis .e 88 to 948 1 to 866       866/871
(99 %)
14 diff
(98.4 %id)
BQ212766 embryonal carcinoma, cell line, testis .e 88 to 902 1 to 819       819/851
(96 %)
8 diff
(99.1 %id)
AA226955 brain, neuroepithelial cells .e 90 to 400 1 to 305       305/314
(97 %)
11 diff
(96.5 %id)
CX761471 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 90 to 805 1 to 716     Submitted on the opposite strand 716/716
(100 %)
1 diff
(99.9 %id)
CR982145 T-Lymphocytes .e 90 to 657 1 to 569       569/569
(100 %)
4 diff
(99.3 %id)
AA233353 brain, neuroepithelial cells .e 93 to 386 1 to 287       287/287
(100 %)
8 diff
(97.3 %id)
BQ439518 large cell carcinoma, lung .e 99 to 1150 17 to 1062       1046/1070
(97 %)
48 diff
(95.6 %id)
BE409197 choriocarcinoma, placenta .e 104 to 779 1 to 672       672/682
(98 %)
4 diff
(99.5 %id)
BE732235 choriocarcinoma, placenta .e 104 to 907 1 to 795       795/968
(82 %)
26 diff
(97.4 %id)
BE274098 melanotic melanoma, skin .e 105 to 805 1 to 702       702/704
(99 %)
27 diff
(96.2 %id)
BU159146 eye, retinoblastoma .e 105 to 933 1 to 830   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 830/834
(99 %)
21 diff
(97.5 %id)
BM314490 Pancreas, Purified pancreatic islet .e 110 to 375 1 to 266       266/266
(100 %)
0 diff
(100 %id)
AI750747 Bone, Hip .e 113 to 542 21 to 451       431/451
(95 %)
6 diff
(98.7 %id)
CN259741 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 117 to 295 1 to 179       179/179
(100 %)
0 diff
(100 %id)
CK821283 Pancreas, Purified pancreatic islet .e 134 to 703 1 to 570     Submitted on the opposite strand 570/570
(100 %)
0 diff
(100 %id)
BQ710479 Spleen .e 137 to 824 1 to 696       696/924
(75 %)
15 diff
(98.4 %id)
AW663188 2 pooled high-grade transitional celltumors, genitourinary tract .e 188 to 446 10 to 268       259/268
(96 %)
6 diff
(97.8 %id)
AW960344   .e 228 to 759 1 to 533       533/535
(99 %)
6 diff
(98.9 %id)
TI_1242418752   .e 235 to 1393 1209 to 71       1139/1209
(94 %)
13 diff
(99.0 %id)
CK821284 Pancreas, Purified pancreatic islet .e 337 to 921 587 to 3     Submitted on the opposite strand 585/587
(99 %)
0 diff
(100 %id)
AW370343 breast .e 344 to 834 488 to 1       488/491
(99 %)
8 diff
(98.4 %id)
AW387723 stomach .e 344 to 837 493 to 3       491/497
(98 %)
2 diff
(99.6 %id)
AW370327 breast .e 348 to 832 1 to 481       481/483
(99 %)
11 diff
(97.8 %id)
CN259738 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 349 to 1025 12 to 687       676/687
(98 %)
6 diff
(99.2 %id)
AW370298 breast .e 353 to 720 368 to 1       368/368
(100 %)
3 diff
(99.2 %id)
AW378273 head_neck .e 382 to 837 1 to 455       455/455
(100 %)
6 diff
(98.7 %id)
CB529291 Aveolar Macrophage, lung .e 397 to 1099 718 to 17   AAA   702/702
(100 %)
1 diff
(99.9 %id)
CB529281 Aveolar Macrophage, lung .e 399 to 1099 717 to 17   AAA   701/701
(100 %)
0 diff
(100 %id)
AW370350 breast .e 423 to 832 409 to 3       407/411
(99 %)
10 diff
(97.6 %id)
AI391502 B-cell, chronic lymphotic leukemia .e 432 to 922 499 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 490/499
(98 %)
1 diff
(99.8 %id)
BQ307907 breast .e 434 to 780 350 to 1       350/365
(95 %)
10 diff
(97.3 %id)
BQ308456 breast .e 434 to 780 350 to 4       347/382
(90 %)
7 diff
(98.2 %id)
BE090540 breast .e 448 to 932 1 to 485       485/485
(100 %)
14 diff
(97.2 %id)
BM314183 Pancreas, Purified pancreatic islet .e 454 to 917 464 to 1       464/464
(100 %)
0 diff
(100 %id)
BP300619   .e 471 to 1077 1 to 606       606/607
(99 %)
4 diff
(99.4 %id)
TI_1241112295   .e 525 to 1394 1 to 869       869/1241
(70 %)
9 diff
(99.3 %id)
BQ430049 epithelioid carcinoma, Pancreas .e 567 to 1447 1 to 881       881/881
(100 %)
6 diff
(99.4 %id)
BU785607 Pancreas, Purified pancreatic islet .e 585 to 1190 1 to 606     Submitted on the opposite strand 606/606
(100 %)
1 diff
(99.9 %id)
BG111751 Bone, osteosarcoma, cell line .e 653 to 1380 1 to 728       728/831
(87 %)
9 diff
(99.0 %id)
AL562443 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 654 to 1329 795 to 120   fully sequenced, AAA   676/676
(100 %)
24 diff
(96.5 %id)
BX356086 Placenta Cot 25-normalized .e 654 to 1460 809 to 1   fully sequenced,   809/809
(100 %)
13 diff
(98.4 %id)
BG198419   .e 685 to 1360 675 to 4     Submitted on the opposite strand 760/774
(98 %)
20 diff
(97.5 %id)
AU146038 whole embryo, mainly head .e 961 to 1496 535 to 1       535/574
(93 %)
15 diff
(97.4 %id)
AU156660 placenta .e 1001 to 1482 482 to 1       482/483
(99 %)
10 diff
(98.0 %id)
AI343879 2 pooled tumors (clear cell type), Kidney .e 1095 to 1488 396 to 3       394/396
(99 %)
0 diff
(100 %id)
AW275520 pooled .e 1099 to 1483 392 to 5       388/397
(97 %)
0 diff
(100 %id)
AA233445 brain, neuroepithelial cells .e 1100 to 1497 401 to 4       398/401
(99 %)
0 diff
(100 %id)
AA522596 metastatic prostate bone lesion .e 1100 to 1482 396 to 13   AAA   384/431
(89 %)
14 diff
(96.8 %id)
AI049705   .e 1100 to 1474 386 to 11   AAA   376/385
(97 %)
1 diff
(99.8 %id)
AI283818 adenocarcinoma, colon .e 1100 to 1482 394 to 12   AAA   383/387
(98 %)
0 diff
(100 %id)
AW613632 2 pooled high-grade transitional celltumors, genitourinary tract .e 1100 to 1482 406 to 24   AAA   383/383
(100 %)
2 diff
(99.5 %id)
FN168103 breast carcinoma .e 1118 to 1214 97 to 1     Submitted on the opposite strand 97/102
(95 %)
3 diff
(97.1 %id)
FN062453 breast carcinoma .e 1124 to 1232 109 to 1     Submitted on the opposite strand 109/109
(100 %)
0 diff
(100 %id)
AI571556 adenocarcinoma, Pancreas .e 1138 to 1491 354 to 1       354/354
(100 %)
0 diff
(100 %id)
FN128649 breast carcinoma .e 1141 to 1248 1 to 107       107/110
(97 %)
3 diff
(97.3 %id)
BG209411   .e 1204 to 1464 319 to 58     Submitted on the opposite strand 262/319
(82 %)
0 diff
(100 %id)
AI689690 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1226 to 1497 279 to 9       271/279
(97 %)
0 diff
(100 %id)
AI916431 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1230 to 1483 254 to 1       254/254
(100 %)
0 diff
(100 %id)
AA507741 Prostate .e 1236 to 1496 340 to 80   AAA   261/261
(100 %)
0 diff
(100 %id)
EC456301 Prostate .e 1291 to 1380 1 to 91       91/91
(100 %)
3 diff
(96.8 %id)
EC545028 Prostate .e 1291 to 1380 1 to 90       90/90
(100 %)
0 diff
(100 %id)
EC578983 Prostate .e 1292 to 1380 1 to 89       89/89
(100 %)
4 diff
(95.6 %id)
AA503661 Prostate .e 1310 to 1497 211 to 24       188/211
(89 %)
0 diff
(100 %id)
BG271998 normal head/neck tissue .e 1388 to 1481 105 to 12   AAA   94/99
(94 %)
2 diff
(98.0 %id)
EC443449 Prostate .e 1390 to 1494 109 to 4       106/109
(97 %)
0 diff
(100 %id)
EC471814 Prostate .e 1390 to 1494 107 to 4       104/107
(97 %)
0 diff
(100 %id)
FN063209 breast carcinoma .e 1403 to 1481 1 to 77       77/80
(96 %)
3 diff
(96.3 %id)
BX640642 human fetal kidney .f 1 to 6800 1 to 6801 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 6801/6801
(100 %)
6 diff
(100.0 %id)
AA552915 Schwannoma tumor .f 1522 to 1963 442 to 1       442/446
(99 %)
3 diff
(99.4 %id)
BF935111 nervous_tumor .f 2094 to 2353 1 to 260       260/261
(99 %)
12 diff
(95.5 %id)
BF931370 nervous_tumor .f 2178 to 2614 449 to 14     Submitted on the opposite strand 436/449
(97 %)
0 diff
(100 %id)
H86318 eye, retina .g 1 to 325 1 to 326   tiling clone, to resequence,   326/326
(100 %)
9 diff
(97.3 %id)
AA012880 eye, retina .g 2 to 202 1 to 200   tiling clone,   200/201
(99 %)
4 diff
(98.1 %id)
AA059039 eye, retina .g 35 to 242 1 to 206   tiling clone,   206/206
(100 %)
5 diff
(97.6 %id)
AA012881 eye, retina .g 729 to 1193 468 to 2   tiling clone,   467/468
(99 %)
1 diff
(99.8 %id)
AA058998 eye, retina .g 751 to 1156 419 to 1   tiling clone,   419/419
(100 %)
15 diff
(96.5 %id)
H86257 eye, retina .g 876 to 1174 299 to 1   to resequence,   299/304
(98 %)
2 diff
(99.4 %id)
AA313441 colon .h 92 to 541 1 to 449   tiling clone,   449/449
(100 %)
1 diff
(99.8 %id)
BM838861 Ascites, stomach .h 96 to 218 1 to 123       123/123
(100 %)
3 diff
(97.6 %id)
CB853643 Human Lung Epithelial cells, lung .h 173 to 811 657 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 639/639
(100 %)
0 diff
(100 %id)
BE090518 breast .h 309 to 549 244 to 4     Submitted on the opposite strand 241/244
(98 %)
1 diff
(99.6 %id)
BF083014 colon_est .h 314 to 509 29 to 222       194/226
(85 %)
8 diff
(96.5 %id)
AI738469 colon, colon tumor, RER+ .h 370 to 811 458 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 443/443
(100 %)
6 diff
(98.7 %id)
AA748446 germinal center B cell .h 382 to 804 442 to 20   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 423/423
(100 %)
0 diff
(100 %id)
TI_159723097   .h 446 to 811 434 to 69 M2V A3R R4A F5S A6X ... AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 848/991
(85 %)
29 diff
(97.1 %id)
BG705158 brain, hippocampus .i 1 to 785 1 to 782 V80S L81C F82S L83C Y84I ... tiling clone,   782/782
(100 %)
6 diff
(99.3 %id)
BI547573 brain, hippocampus .i 1 to 794 1 to 800 G201C tiling clone,   800/800
(100 %)
11 diff
(98.7 %id)
TI_44168929   .i 2 to 794 84 to 882 G201C     799/882
(90 %)
13 diff
(98.6 %id)
TI_151746100   .i 348 to 1268 972 to 60   tiling clone,   913/1033
(88 %)
19 diff
(98.2 %id)
CN413987 embryonic stem cells, cell lines H1, H7, andH9 .i 891 to 1349 1 to 461   tiling clone,   461/461
(100 %)
7 diff
(98.5 %id)
CN386826 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 1 to 633 1 to 634 exact tiling clone,   634/634
(100 %)
1 diff
(99.9 %id)
H37954 eye, retina .k 1 to 404 1 to 406   tiling clone,   406/406
(100 %)
7 diff
(98.3 %id)
BG398788 Kidney .k 16 to 679 1 to 661   tiling clone,   661/732
(90 %)
19 diff
(97.5 %id)
BI668370 brain, hypothalamus .k 17 to 760 6 to 748   tiling clone,   743/750
(99 %)
15 diff
(98.0 %id)
TI_44343721   .k 17 to 760 84 to 826       743/828
(89 %)
15 diff
(98.2 %id)
BG398679 Kidney .k 22 to 717 1 to 702   tiling clone,   702/847
(82 %)
15 diff
(98.3 %id)
DB213647 trachea .k 30 to 567 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
AK024625 adipose tissue .k 747 to 2751 26 to 2031   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2006/2031
(98 %)
10 diff
(99.6 %id)
CB998485 Blood vessels - aorta, basilar and artery .l 1 to 728 1 to 728 exact tiling clone,   728/728
(100 %)
5 diff
(99.4 %id)
BC062586 Blood, adult leukocytes .m 1 to 1614 1 to 1614 exact tiling clone, available from MGC, AAA   1614/1614
(100 %)
1 diff
(100.0 %id)
BI906474 leukocyte .m 1 to 851 1 to 848   available from MGC,   848/860
(98 %)
17 diff
(98.1 %id)
TI_57232754   .m 1 to 805 38 to 843       806/897
(89 %)
7 diff
(99.3 %id)
CR606199 fetal brain .m 7 to 1618 1 to 1612 exact tiling clone,   1612/1612
(100 %)
0 diff
(100 %id)
BX441906 brain, fetal brain .m 7 to 945 1 to 932   fully sequenced,   932/932
(100 %)
23 diff
(97.6 %id)
BP376901 uterus .m 13 to 599 1 to 586       586/586
(100 %)
5 diff
(99.2 %id)
DA970149 stomach .m 22 to 593 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CR606074 Placenta Cot 25-normalized .m 27 to 1582 1 to 1556 exact     1556/1556
(100 %)
0 diff
(100 %id)
BX377084 Placenta Cot 25-normalized .m 27 to 807 1 to 781       781/1005
(77 %)
1 diff
(100.0 %id)
CN259739 embryonic stem cells, cell lines H1, H7, andH9 .m 33 to 687 1 to 653       653/653
(100 %)
2 diff
(99.7 %id)
BF981029 duodenal adenocarcinoma, cell line, small intestine .m 35 to 613 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BM922732 leukocyte .m 36 to 970 1 to 949       949/1026
(92 %)
35 diff
(96.6 %id)
EC580934 Prostate .m 651 to 755 1 to 104       104/104
(100 %)
4 diff
(96.2 %id)
BX377083 Placenta Cot 25-normalized .m 829 to 1582 754 to 1       754/1182
(63 %)
1 diff
(100.0 %id)
BX413434 brain, fetal brain .m 915 to 1580 718 to 50   fully sequenced,   669/718
(93 %)
7 diff
(99.1 %id)
CN259743 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n-u 1 to 681 1 to 681 exact tiling clone,   681/681
(100 %)
1 diff
(99.9 %id)
DB479832 hippocampus .o 1 to 502 1 to 502 exact tiling clone,   502/504
(99 %)
2 diff
(99.7 %id)
BM918991 pooled pancreas and spleen .p-u 1 to 665 18 to 682   tiling clone,   665/1124
(59 %)
7 diff
(99.4 %id)
CB238798 lung adenocarcinoma .p-u 391 to 952 562 to 1 exact   Submitted on the opposite strand 562/562
(100 %)
3 diff
(99.5 %id)
TI_154110342   .p-u 405 to 1211 863 to 62 K2R M3C V4A P5K K6L ... AAA   802/943
(85 %)
12 diff
(98.8 %id)
BG213038   .p-u 409 to 1198 794 to 12 K2R M3C V4P P5K K6T ...   Submitted on the opposite strand 783/844
(92 %)
0 diff
(100 %id)
BG211431   .p-u 411 to 1193 796 to 15 K2R M3W V4C P5K K6T ...   Submitted on the opposite strand 782/827
(94 %)
0 diff
(100 %id)
BP306677   .p-u 422 to 1003 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AA173459   .p-u 434 to 790 1 to 357       357/357
(100 %)
0 diff
(100 %id)
AL048372 uterus .p-u 436 to 1225 819 to 27   AAA   793/793
(100 %)
12 diff
(98.5 %id)
AI681821 carcinoid, lung .p-u 446 to 913 1 to 468     Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
BG216809   .p-u 462 to 1203 748 to 9     Submitted on the opposite strand 740/755
(98 %)
0 diff
(100 %id)
BE895142 melanotic melanoma, skin .p-u 490 to 1165 1 to 681       681/683
(99 %)
11 diff
(98.4 %id)
CB528468 Aveolar Macrophage, lung .p-u 494 to 1211 734 to 19   AAA   716/716
(100 %)
2 diff
(99.8 %id)
BU929508 placenta .p-u 496 to 1142 1 to 659   AAA   659/760
(86 %)
19 diff
(97.5 %id)
TI_149304138   .p-u 496 to 1211 802 to 87   AAA   716/716
(100 %)
2 diff
(99.8 %id)
CA448088 Chondrosarcoma, Left Pubic Bone .p-u 511 to 1211 719 to 19   AAA   701/701
(100 %)
1 diff
(99.9 %id)
CA429995 Cell Line, Chondrosarcoma .p-u 512 to 1225 729 to 19   tiling clone, AAA   711/711
(100 %)
3 diff
(99.6 %id)
BM982012 lung, Primary Lung Cystic Fibrosis EpithelialCells .p-u 517 to 1211 713 to 19   AAA   695/695
(100 %)
2 diff
(99.8 %id)
BQ301562 bocio_tumor .p-u 537 to 1009 467 to 3       465/484
(96 %)
0 diff
(100 %id)
AW368837 head_neck .p-u 538 to 871 338 to 4       335/338
(99 %)
0 diff
(100 %id)
BQ015988 lung, Metastatic Chondrosarcoma .p-u 584 to 1225 660 to 19   AAA   642/642
(100 %)
0 diff
(100 %id)
AW996829 breast_normal .p-u 586 to 1125 540 to 1     Submitted on the opposite strand 540/540
(100 %)
3 diff
(99.5 %id)
AW996839 breast_normal .p-u 586 to 1125 541 to 1     Submitted on the opposite strand 541/541
(100 %)
1 diff
(99.9 %id)
BE814076 breast_normal .p-u 586 to 917 31 to 366       336/366
(91 %)
6 diff
(98.4 %id)
BF857498 prostate_tumor .p-u 595 to 999 1 to 406       406/406
(100 %)
14 diff
(96.6 %id)
TI_1242416390   .p-u 605 to 1122 1 to 519       519/1272
(40 %)
5 diff
(99.7 %id)
BX369565   .p-u 607 to 1207 1 to 599       599/599
(100 %)
4 diff
(99.4 %id)
BX369566   .p-u 614 to 1203 8 to 596   AAA   589/596
(98 %)
6 diff
(99.0 %id)
CA424850 cell lines, Chondrosarcoma .p-u 648 to 1211 582 to 19   AAA   564/564
(100 %)
0 diff
(100 %id)
TI_149306277   .p-u 651 to 1225 688 to 115   AAA   574/927
(61 %)
6 diff
(99.4 %id)
BM992987 lung, Metastatic Chondrosarcoma .p-u 679 to 1211 550 to 19   AAA   532/532
(100 %)
2 diff
(99.7 %id)
BE501490 Kidney .p-u 690 to 1220 530 to 1       530/530
(100 %)
2 diff
(99.7 %id)
BF814548 colon_ins .p-u 692 to 1170 11 to 487       477/487
(97 %)
6 diff
(98.8 %id)
BF816391 colon_ins .p-u 692 to 1175 488 to 8     Submitted on the opposite strand 481/602
(79 %)
0 diff
(100 %id)
BE090543 breast .p-u 694 to 1098 410 to 4     Submitted on the opposite strand 407/410
(99 %)
0 diff
(100 %id)
BF001981 colon, colon tumor, RER+ .p-u 694 to 1210 517 to 1       517/517
(100 %)
1 diff
(99.9 %id)
BF817659 colon_ins .p-u 696 to 1177 486 to 7     Submitted on the opposite strand 480/486
(98 %)
0 diff
(100 %id)
AW300214 Kidney .p-u 700 to 1222 523 to 1       523/523
(100 %)
2 diff
(99.7 %id)
BU686332 lung, Primary Lung Epithelial Cells .p-u 724 to 1225 515 to 14   AAA   502/502
(100 %)
0 diff
(100 %id)
AA773630 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .p-u 730 to 1185 456 to 1     Submitted on the opposite strand 456/456
(100 %)
2 diff
(99.6 %id)
CB110550 Liver .p-u 732 to 1211 1 to 480   AAA   480/480
(100 %)
2 diff
(99.6 %id)
BI861850 breast, mammary adenocarcinoma, cell line .p-u 733 to 1220 1 to 488   AAA   488/488
(100 %)
1 diff
(99.8 %id)
TI_57191361   .p-u 733 to 1220 54 to 541   AAA   488/488
(100 %)
1 diff
(99.8 %id)
AW518678 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .p-u 747 to 1226 480 to 1   tiling clone,   480/480
(100 %)
0 diff
(100 %id)
AI281162 adenocarcinoma, colon .p-u 759 to 1205 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AI952097 lung, two pooled squamous cell carcinomas .p-u 763 to 1223 465 to 5       461/465
(99 %)
0 diff
(100 %id)
DB565992 hypothalamus .p-u 770 to 1225 1 to 456     Submitted on the opposite strand 456/456
(100 %)
1 diff
(99.8 %id)
AW169894 pooled .p-u 773 to 1226 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
DB548952 hippocampus .p-u 774 to 1220 1 to 447     Submitted on the opposite strand 447/447
(100 %)
1 diff
(99.8 %id)
DB548564 hippocampus .p-u 775 to 1225 1 to 451     Submitted on the opposite strand 451/451
(100 %)
1 diff
(99.8 %id)
DB516756 testis .p-u 785 to 1225 1 to 441     Submitted on the opposite strand 441/441
(100 %)
1 diff
(99.8 %id)
AA164230   .p-u 788 to 1021 1 to 238   fully sequenced,   238/238
(100 %)
5 diff
(97.9 %id)
BM987239 mixed .p-u 790 to 1220 448 to 19   AAA   430/430
(100 %)
2 diff
(99.6 %id)
AA364744 pineal body .p-u 791 to 1025 1 to 235       235/236
(99 %)
2 diff
(99.2 %id)
FN160642 breast carcinoma .p-u 802 to 904 1 to 104       104/104
(100 %)
7 diff
(93.3 %id)
FN055970 breast carcinoma .p-u 805 to 904 1 to 100       100/100
(100 %)
0 diff
(100 %id)
AI801234 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .p-u 806 to 1212 410 to 4       407/410
(99 %)
0 diff
(100 %id)
AW959863   .p-u 807 to 1220 1 to 414   AAA   414/414
(100 %)
1 diff
(99.8 %id)
FN135101 breast carcinoma .p-u 817 to 881 65 to 1     Submitted on the opposite strand 65/66
(98 %)
1 diff
(98.5 %id)
AA173403   .p-u 838 to 1213 380 to 1       380/381
(99 %)
3 diff
(99.3 %id)
AA164231   .p-u 991 to 1225 268 to 32   fully sequenced, AAA   237/237
(100 %)
2 diff
(99.2 %id)
BQ777935 Pancreas, Purified pancreatic islet .q 1 to 309 1 to 309   tiling clone, fully sequenced,   309/309
(100 %)
6 diff
(98.1 %id)
AI827469 pooled .q 47 to 574 535 to 8   tiling clone,   528/535
(98 %)
0 diff
(100 %id)
AA888811 parathyroid gland, parathyroid tumor .q 187 to 540 366 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 353/353
(100 %)
2 diff
(99.5 %id)
AA916957 pooled .q 237 to 551 326 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 315/315
(100 %)
0 diff
(100 %id)
BQ777633 Pancreas, Purified pancreatic islet .q 248 to 574 329 to 3   tiling clone, fully sequenced,   327/329
(99 %)
0 diff
(100 %id)
TI_149281327   .r 1 to 659 139 to 797 L2V E4A K5* tiling clone, Submitted on the opposite strand 659/809
(81 %)
21 diff
(97.5 %id)
BM983324 lung, Primary Lung Epithelial Cells .r 1 to 391 27 to 417 L2V E4A K5* tiling clone, Submitted on the opposite strand 391/403
(97 %)
14 diff
(96.6 %id)
BM923950 pooled colon, kidney, stomach .s 1 to 966 1 to 971 T103N L126P tiling clone,   971/972
(99 %)
15 diff
(98.5 %id)
BP212748 cerebrum .s 225 to 615 1 to 396       396/582
(68 %)
6 diff
(99.0 %id)
AI768964 pooled .s 374 to 870 496 to 1 K22R I23S Q24S S25H S26L ...     496/496
(100 %)
1 diff
(99.8 %id)
BF590073 pooled .s 392 to 868 481 to 3 A6G P38S F57I K58*     479/481
(99 %)
1 diff
(99.8 %id)
BE566406 bladder, carcinoma, cell line .s 412 to 950 1 to 541   tiling clone,   541/756
(71 %)
19 diff
(97.5 %id)
FN096518 breast carcinoma .s 414 to 505 1 to 94       92/94
(97 %)
7 diff
(92.6 %id)
BQ318591 colon .s 431 to 807 384 to 1       384/393
(97 %)
24 diff
(93.9 %id)
BG108786 retina, Retinal Pigment Epithelium sheets .s 437 to 734 1 to 293       293/293
(100 %)
9 diff
(97.0 %id)
BF431850 pooled .s 473 to 871 399 to 1   tiling clone,   399/399
(100 %)
1 diff
(99.8 %id)
NM_001077447.1   .t 1 to 1044 1 to 1044 exact RefSeq,   1044/1044
(100 %)
0 diff
(100 %id)
BF207448 bladder, carcinoma, cell line .t 19 to 692 1 to 659 L44W V45L D47I W48G A49L ...     659/840
(78 %)
25 diff
(97.1 %id)
AI206413 Kidney .t 23 to 515 1 to 493     Submitted on the opposite strand 493/493
(100 %)
7 diff
(98.6 %id)
AI910753 Kidney .t 23 to 448 1 to 427   tiling clone, Submitted on the opposite strand 427/427
(100 %)
4 diff
(99.1 %id)
BF668859 brain, primitive neuroectoderm .t 30 to 622 1 to 584 A7V V8C S9Q D10I F11S ...     584/806
(72 %)
16 diff
(98.1 %id)
BP261149 small intestine .t 32 to 613 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
BP261491 small intestine .t 33 to 594 1 to 562 I23S     562/562
(100 %)
4 diff
(99.3 %id)
BG702056 brain, hippocampus .t 37 to 821 1 to 789 exact tiling clone,   789/789
(100 %)
12 diff
(98.5 %id)
CD104470 Pooled-Skin .t 38 to 638 1 to 607 exact AAA   607/812
(74 %)
14 diff
(98.3 %id)
BP211065 cerebellum .t 42 to 625 1 to 584 exact     584/584
(100 %)
0 diff
(100 %id)
BC012383 Ovary, adenocarcinoma .t 47 to 1028 40 to 1021 exact tiling clone, AAA   982/1021
(96 %)
7 diff
(99.4 %id)
BF035092 adenocarcinoma, ovary .t 47 to 751 19 to 719 exact     701/812
(86 %)
32 diff
(96.1 %id)
CD693683 normal nasopharynx .t 49 to 648 29 to 627 exact     599/627
(95 %)
8 diff
(98.8 %id)
CD705379 normal nasopharynx .t 49 to 307 32 to 290       259/290
(89 %)
12 diff
(95.9 %id)
AI379082 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .t 52 to 479 1 to 427     Submitted on the opposite strand 427/427
(100 %)
3 diff
(99.3 %id)
AI435925 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .t 52 to 585 1 to 534 F133X N138X   Submitted on the opposite strand 534/534
(100 %)
0 diff
(100 %id)
BG485423 lung .t 52 to 744 1 to 708 V97G T98N K99Q D100R S101L ...     708/887
(79 %)
29 diff
(96.8 %id)
BF575376 muscle (skeletal) .t 55 to 750 1 to 690 L44W V45L D47I W48G A49L ...     690/827
(83 %)
37 diff
(95.6 %id)
CK002374 brain/CNS, Bulk tissue from Human Spinal cord .t 55 to 707 1 to 651 exact     651/657
(99 %)
6 diff
(99.1 %id)
BG613929 embryonal carcinoma, testis .t 56 to 859 1 to 800 K46Q D47R W48L A49G P50S ...     800/806
(99 %)
14 diff
(98.3 %id)
BF671740 muscle (skeletal) .t 57 to 692 1 to 622 W48G A49L A52H F53L I54*     622/868
(71 %)
20 diff
(97.7 %id)
BF680213 Prostate .t 57 to 721 1 to 669 L44W V45L D47M W48G A49S ...     669/732
(91 %)
39 diff
(94.7 %id)
BG432822 Kidney .t 57 to 862 1 to 803 exact     803/834
(96 %)
24 diff
(97.2 %id)
BG431815 Kidney .t 57 to 855 1 to 802 exact     802/1027
(78 %)
25 diff
(97.6 %id)
BG536422 lung .t 57 to 812 1 to 745 L44X L59S L74X I96M V97C ...     745/831
(89 %)
31 diff
(96.3 %id)
BM838544 Ascites, stomach .t 58 to 641 1 to 583 exact     583/583
(100 %)
1 diff
(99.9 %id)
BG566474 Liver .t 60 to 717 1 to 661 M18I I23V S89L R90T Q91T ...     661/662
(99 %)
19 diff
(97.2 %id)
CB106569 Liver .t 61 to 468 1 to 407       407/407
(100 %)
1 diff
(99.8 %id)
BM832398 stomach .t 61 to 327 1 to 267       267/267
(100 %)
3 diff
(98.9 %id)
BE973872 Prostate .t 63 to 649 1 to 579 A7V V8C S9Q D10I F11S ...     579/851
(68 %)
16 diff
(98.2 %id)
BM833488 stomach .t 63 to 481 1 to 415       415/415
(100 %)
8 diff
(98.1 %id)
CF126223 Chondrosarcoma Lung Metastasis cell lines, lung .t 70 to 890 1 to 820 exact     822/820
(100 %)
2 diff
(99.8 %id)
TI_154189182   .t 70 to 1043 51 to 1009 exact AAA   961/959
(100 %)
26 diff
(97.3 %id)
AA249434   .t 71 to 370 1 to 299       299/301
(99 %)
3 diff
(99.1 %id)
CN481665 eye .t 72 to 679 1 to 608 exact     608/608
(100 %)
0 diff
(100 %id)
CN259740 embryonic stem cells, DMSO-treated H9 cellline .t 73 to 828 9 to 764 exact tiling clone,   756/764
(98 %)
6 diff
(99.3 %id)
BQ439031 epithelioid carcinoma, Pancreas .t 74 to 892 1 to 828 V45G E117Q     828/870
(95 %)
16 diff
(98.2 %id)
BE564313 bladder, carcinoma, cell line .t 75 to 649 1 to 582 L44W V45L D47I W48G A49L ...     582/692
(84 %)
26 diff
(96.3 %id)
AA366263 Pancreas .t 87 to 417 1 to 334       334/335
(99 %)
7 diff
(98.0 %id)
FN136836 breast carcinoma .t 87 to 186 101 to 3     Submitted on the opposite strand 99/101
(98 %)
0 diff
(100 %id)
BM831706 stomach .t 98 to 588 1 to 491 exact     491/491
(100 %)
0 diff
(100 %id)
DA265793 caudate nucleus .u 1 to 551 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
FN051998 breast carcinoma .u 156 to 216 1 to 61       61/62
(98 %)
1 diff
(98.4 %id)
AW168613 bowel (skin primary), metastatic melanoma to bowel .u 157 to 262 119 to 13       107/120
(89 %)
1 diff
(99.2 %id)
BG701107 brain, hippocampus .va 1 to 752 1 to 755 V39C S41V S42L Q43P N44K ... tiling clone,   755/758
(99 %)
12 diff
(98.5 %id)
CA396665 eye, RPE/choroid .va 366 to 1001 1 to 636 exact tiling clone,   636/636
(100 %)
0 diff
(100 %id)
BQ712238 Spleen .vb 1 to 644 1 to 648   tiling clone,   648/902
(71 %)
20 diff
(97.8 %id)
BX504870   .vb 90 to 724 635 to 1   tiling clone,   635/635
(100 %)
1 diff
(99.9 %id)
TI_57243819   .vb 247 to 914 34 to 701   tiling clone,   668/766
(87 %)
9 diff
(98.9 %id)
BI917638 brain .vb 249 to 914 1 to 666       666/731
(91 %)
3 diff
(99.6 %id)
AI917764 pooled germ cell tumors .vb 2772 to 3221 450 to 1   tiling clone,   450/450
(100 %)
0 diff
(100 %id)
AW196457 pooled germ cell tumors .vb 2952 to 3221 271 to 1       271/271
(100 %)
1 diff
(99.7 %id)
DB451277 testis .vc 1 to 488 1 to 489 exact tiling clone,   489/489
(100 %)
1 diff
(99.8 %id)
BP872074 embryonal kidney .vc 50 to 641 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
BJ990298 hepatoblastoma .vc 79 to 667 12 to 600   tiling clone,   589/600
(98 %)
6 diff
(99.0 %id)
BF207706 bladder, carcinoma, cell line .vc 256 to 918 1 to 655       655/674
(97 %)
13 diff
(98.1 %id)
BF028395 bladder, carcinoma, cell line .vc 275 to 758 1 to 484       484/484
(100 %)
2 diff
(99.6 %id)
BF028021 bladder, carcinoma, cell line .vc 276 to 879 1 to 599       599/895
(66 %)
16 diff
(98.3 %id)
BF029015 bladder, carcinoma, cell line .vc 277 to 849 1 to 562       562/903
(62 %)
19 diff
(97.9 %id)
AA094912   .vc 502 to 767 1 to 262       262/263
(99 %)
6 diff
(97.8 %id)
BE326442 carcinoid, lung .vc 531 to 952 1 to 422     Submitted on the opposite strand 422/422
(100 %)
3 diff
(99.3 %id)
BQ323850 colon_ins .vc 536 to 952 424 to 12       413/424
(97 %)
0 diff
(100 %id)
BE549478 cervical carcinoma cell line, cervix .vc 537 to 952 51 to 453   tiling clone,   403/471
(85 %)
24 diff
(95.0 %id)
AW375878 colon .vc 551 to 659 117 to 9       109/117
(93 %)
0 diff
(100 %id)
DN919882   .vc 632 to 718 1 to 87       87/87
(100 %)
0 diff
(100 %id)
CB117277 Liver .vc 639 to 939 1 to 301   tiling clone,   301/301
(100 %)
3 diff
(99.1 %id)
FN088794 breast carcinoma .vc 645 to 732 100 to 13     Submitted on the opposite strand 88/100
(88 %)
0 diff
(100 %id)
FN165109 breast carcinoma .vc 685 to 797 113 to 1     Submitted on the opposite strand 113/113
(100 %)
4 diff
(96.5 %id)
BE925957 breast_normal .vc 714 to 839 11 to 133       123/133
(92 %)
6 diff
(95.5 %id)
AW371099 breast .vc 717 to 844 1 to 128       128/139
(92 %)
2 diff
(98.6 %id)
BF752212 breast_normal .vc 720 to 915 1 to 200       200/205
(97 %)
14 diff
(93.2 %id)
FN121262 breast carcinoma .vc 730 to 834 104 to 1     Submitted on the opposite strand 104/104
(100 %)
5 diff
(95.2 %id)
FN164684 breast carcinoma .vc 821 to 936 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
BX117895 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vc 1289 to 1752 1 to 464   tiling clone,   464/464
(100 %)
0 diff
(100 %id)
BE552430 Kidney .vc 1534 to 2071 538 to 1       538/538
(100 %)
0 diff
(100 %id)
BF439486 pooled .vc 1570 to 2152 588 to 4       585/588
(99 %)
0 diff
(100 %id)
BJ990299 hepatoblastoma .vc 1597 to 2136 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AI435857 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vc 1638 to 2156 519 to 1   tiling clone,   519/519
(100 %)
0 diff
(100 %id)
AI810579 Prostate .vc 1800 to 2156 372 to 16   AAA   357/357
(100 %)
2 diff
(99.5 %id)
BE552437 Kidney .vc 1800 to 2069 271 to 1       271/272
(99 %)
3 diff
(98.9 %id)
BM724119 eye, fetal eye .vd 1 to 735 1 to 732 exact tiling clone, to resequence, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 732/732
(100 %)
4 diff
(99.5 %id)
AA047229 eye, retina .vd 88 to 560 478 to 2 S12X G17E     477/478
(99 %)
5 diff
(99.0 %id)
BM680304 eye, fetal eye .vd 850 to 1614 781 to 17   tiling clone, to resequence, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 765/765
(100 %)
2 diff
(99.8 %id)
AV750128 Pituitary .ve-u 1 to 398 1 to 394 exact tiling clone,   394/414
(95 %)
7 diff
(98.4 %id)
FN055204 breast carcinoma .ve-u 175 to 237 63 to 1     Submitted on the opposite strand 63/63
(100 %)
0 diff
(100 %id)
BF885913 testis_normal .ve-u 252 to 674 23 to 446   tiling clone,   424/446
(95 %)
9 diff
(98.0 %id)
BE672610 carcinoid, lung .vf-u 1 to 560 562 to 3 exact tiling clone,   560/562
(99 %)
0 diff
(100 %id)
AW293429   .vf-u 29 to 559 548 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 531/531
(100 %)
2 diff
(99.7 %id)
BF939028 carcinoid, lung .vf-u 46 to 560 518 to 3       516/518
(99 %)
0 diff
(100 %id)
AI457871 carcinoid, lung .vf-u 97 to 558 462 to 1       462/462
(100 %)
0 diff
(100 %id)
AW295278   .vf-u 188 to 559 389 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 372/372
(100 %)
3 diff
(99.2 %id)
DA800771 brain .vg 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
2 diff
(99.7 %id)
CN386825 embryonic stem cells, DMSO-treated H9 cellline .vg 63 to 485 1 to 423       423/423
(100 %)
3 diff
(99.3 %id)
BQ026121 placenta .vh-u 1 to 476 495 to 18 K4E K5E I7E V8* tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 478/478
(100 %)
5 diff
(99.0 %id)
AI123463   .vi 1 to 362 365 to 4 exact tiling clone,   362/365
(99 %)
0 diff
(100 %id)
AI025472   .vi 58 to 362 307 to 3   tiling clone,   305/307
(99 %)
0 diff
(100 %id)
AW896534 nervous_normal .vj 1 to 304 1 to 305 E3A E4K Q20H Y21T R22G ... tiling clone,   305/305
(100 %)
21 diff
(93.2 %id)
AW896438 nervous_normal .vj 12 to 266 10 to 269   tiling clone,   260/269
(96 %)
24 diff
(91.1 %id)
AW896500 nervous_normal .vj 20 to 287 18 to 285   tiling clone,   268/285
(94 %)
7 diff
(97.6 %id)
AW090439 brain, tumor, 5 pooled (see description) .vk-u 1 to 289 289 to 1 exact tiling clone,   289/289
(100 %)
1 diff
(99.7 %id)
BE930975 placenta_normal Gene PPCSandCCDC30, variant not shown         Suspected internal deletion, this clone was ignored    
BG193187   Gene PPCSandCCDC30, variant not shown         This clone was ignored    
BG220167   Gene PPCSandCCDC30, variant not shown         This clone was ignored    
BY796115 eye Gene PPCSandCCDC30, variant not shown         Suspected internal deletion, this clone was ignored    
DB147526 thymus Gene PPCSandCCDC30, variant not shown       capped This clone was ignored    
DB345847 thymus Gene PPCSandCCDC30, variant not shown         This clone was ignored    
DB230025 trachea Gene PPCSandCCDC30, variant not shown       capped This clone was ignored    
DB349956 trachea Gene PPCSandCCDC30, variant not shown         This clone was ignored    
TI_813709310   Gene PPCSandCCDC30, variant not shown         This clone was ignored    
TI_813709311   Gene PPCSandCCDC30, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o, .p-u, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve-u, .vf-u, .vg, .vh-u, .vi, .vj, .vk-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI